Bank of New York Mellon
NERV icon

Bank of New York Mellon’s Minerva Neurosciences NERV Stock Holding History

Bank of New York Mellon’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
+75,580
New +$410K ﹤0.01% 3830
2022
Q2 		– Sell
-2,463
Closed -$16K – 4667
2022
Q1 		$16K Hold
2,463
– – ﹤0.01% 4625
2021
Q4 		$16K Hold
2,463
– – ﹤0.01% 4598
2021
Q3 		$34K Sell
2,463
-1,382
-36% -$20.8K ﹤0.01% 4480
2021
Q2 		$71K Sell
3,845
-11,199
-74% -$241K ﹤0.01% 4274
2021
Q1 		$352K Sell
15,044
-231
-2% -$5.77K ﹤0.01% 3848
2020
Q4 		$286K Buy
15,275
+1,330
+10% +$33.5K ﹤0.01% 3847
2020
Q3 		$355K Sell
13,945
-99
-0.7% -$2.68K ﹤0.01% 3648
2020
Q2 		$406K Buy
14,044
+1,664
+13% +$97.6K ﹤0.01% 3577
2020
Q1 		$597K Sell
12,380
-191
-2% -$11.5K ﹤0.01% 3262
2019
Q4 		$715K Sell
12,571
-2,871
-19% -$127K ﹤0.01% 3399
2019
Q3 		$957K Sell
15,442
-484
-3% -$27.4K ﹤0.01% 3200
2019
Q2 		$717K Sell
15,926
-988
-6% -$49.5K ﹤0.01% 3417
2019
Q1 		$1.06M Buy
16,914
+211
+1% +$12.7K ﹤0.01% 3133
2018
Q4 		$900K Buy
16,703
+848
+5% +$62.1K ﹤0.01% 3168
2018
Q3 		$1.59M Buy
15,855
+2,882
+22% +$217K ﹤0.01% 2989
2018
Q2 		$857K Sell
12,973
-85
-0.7% -$5.16K ﹤0.01% 3335
2018
Q1 		$652K Sell
13,058
-836
-6% -$40.2K ﹤0.01% 3447
2017
Q4 		$672K Sell
13,894
-1,250
-8% -$62K ﹤0.01% 3462
2017
Q3 		$921K Buy
15,144
+3,778
+33% +$217K ﹤0.01% 3269
2017
Q2 		$805K Buy
11,366
+1,341
+13% +$86.8K ﹤0.01% 3374
2017
Q1 		$649K Buy
10,025
+161
+2% +$12.5K ﹤0.01% 3450
2016
Q4 		$927K Buy
9,864
+2,469
+33% +$252K ﹤0.01% 3300
2016
Q3 		$835K Buy
7,395
+1,004
+16% +$97.4K ﹤0.01% 3267
2016
Q2 		$523K Buy
+6,391
New +$406K ﹤0.01% 3518

Other funds holding NERV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Bank of New York Mellon's NERV Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 75,580 shares worth $419K. The stake represents ﹤0.01% of the portfolio and ranks #3830 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in NERV as recently as Q1 2022.

Bank of New York Mellon first reported a position in NERV in Q2 2016 and has held it in 25 quarters since. The position peaked at $1.59M in Q3 2018. 18 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Bank of New York Mellon held 75,580 shares of Minerva Neurosciences worth $419K as of Q2 2026.
  • Minerva Neurosciences was a new Bank of New York Mellon position in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3830 holding.
  • Bank of New York Mellon first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 25 quarters since.
  • Bank of New York Mellon's Minerva Neurosciences position peaked at $1.59M in Q3 2018.
  • 18 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.